Skip to main content
University of California San Francisco
UCSF School of Medicine
|
Department of Medicine
UCSF Medical Center
Search
Search
Main navigation
About Us
From the Chiefs
History
Administration
Honors & Awards
Visiting Professors
Faculty
Education
Medical Students
Residency Program
Fellowship Program
How to Apply
Current Fellows
Alumni
Research Training Program
Rheumatology Board Review Course
Patient Care
General Rheumatology
Ankylosing Spondylitis
Lupus Clinic
Rheumatoid Arthritis Clinic
Scleroderma Center
About Scleroderma
Message from Our Directors
Meet Our Team
Research and Trials
How to Be Evaluated
Sjogren's Syndrome
Vasculitis Clinic
Research
Basic and Translational
Genetics and Epigenetics
Clinical Trials and Observational Studies
Disease-Specific-Research-Programs
Outcomes and Informatics Research
Research Centers
Precision Medicine in Rheumatology
Overview of the Research Program of the NCCAF Center of Excellence
UCSF Multidisciplinary Clinical Research Center
UCSF Center for the Rheumatic Diseases
Funding Opportunities
Publications
Russell/Engleman Center
Giving
Breadcrumb
Home
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study.
Annals of the rheumatic diseases
2021
https://researcherprofiles.org/profile/193619338
33906853
